Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      1.00p
  • 52 Week High: 12.00p
  • 52 Week Low: 5.00p
  • Currency: UK Pounds
  • Shares Issued: 6,141m
  • Volume: 0
  • RiskGrade: 268

Latest Deals

Traded Action Notifier PriceAmountValue
28-Feb-25 Placing Shaun Furlong 0.100p 12,000,000 £12,000.00
17-Jan-25 Placing Shaun Furlong 0.000p 7 £0.00
14-Jan-25 Exercise of option Zheqing Shen 4.00p 457,937,504 £18,317,499.75
14-Jan-25 Exercise of option Anthony Parker 4.00p 229,562,496 £9,182,499.63

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
14-Jan-25 Exercise of option Zheqing Shen 4.00p 457,937,504 £18,317,499.75
14-Jan-25 Exercise of option Anthony Parker 4.00p 229,562,496 £9,182,499.63
28-Feb-25 Placing Shaun Furlong 0.100p 12,000,000 £12,000.00
17-Jan-25 Placing Shaun Furlong 0.000p 7 £0.00

Director Shareholdings

Notifier Holding Value*
Zheqing Shen 705,872,556 £0
Shaun Furlong 12,001,507 £0
Manuel Llobet 5,001,200 £0
Peter Jensen 300,000 £0
Tunde Otulana 50,000 £0

Major Shareholders

Notifier** Holding Value*
ZQ Capital Management Limited 3,098,231,533 £0
SkyGem Acquisition Limited 3,098,231,533 £0
SkyGem Acquisition Limited 2,850,296,476 £0
Southern Fox Investments Limited 1,307,377,398 £0
CFR International SPA & Associated Holding 240,584,571 £0
Odey Asset Management LLP 43,747,523 £0
River and Mercantile Asset Management LLP 30,520,000 £0
Invesco Perpetual Asset Management 28,618,373 £0
Invesco Plc 28,618,373 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 12.00p
Closing Price Change 1.00p
% Change 0.00 %
52 Week High 12.00p
52 Week Low 5.00p
Volume 0
Shares Issued 6,141m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet

Top of Page